Seelos Therapeutics Inc (NQ: SEEL )
0.7498
-0.0902
(-10.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
All News about Seelos Therapeutics Inc
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 31, 2023
March 31, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/30/seel.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/psychedelic_image_61.png?width=1200&height=800&fit=crop)
Psychedelic Stock Gainers And Losers From March 29, 2023
March 29, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 28, 2023
March 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 27, 2023
March 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
GH Research, Cybin Among Top Psychedelic Movers Of Today
March 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/24/meta_platforms_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 22, 2023
March 22, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 21, 2023
March 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 20, 2023
March 20, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 17, 2023
March 17, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2023/psychedelic_image_49.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/psychedelic_image_46.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From March 2, 2023
March 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From February 28, 2023
February 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From February 27, 2023
February 27, 2023
Via Benzinga
![](https://munknee.com/wp-content/uploads/2020/11/orig_brain-4866447_640-272x300.png)
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
February 26, 2023
Via Talk Markets
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From February 24, 2023
February 24, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From February 23, 2023
February 23, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.